FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 08/13/2025 |
3. Issuer Name and Ticker or Trading Symbol
MIAMI INTERNATIONAL HOLDINGS, INC. [ MIAX ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Series B Preferred Stock | (1) | (1) | Common Stock | 10,000 | (1) | D | |
Nonvoting Common Stock | (2) | (2) | Common Stock | 14,083 | (2) | D | |
Stock Option (Right to Buy) | (3) | 06/19/2026 | Nonvoting Common Stock | 11,000 | $12 | D | |
Stock Option (Right to Buy) | (3) | 05/31/2027 | Nonvoting Common Stock | 18,000 | $12 | D | |
Stock Option (Right to Buy) | (3) | 04/30/2028 | Nonvoting Common Stock | 18,000 | $12 | D | |
Stock Option (Right to Buy) | (3) | 05/31/2029 | Nonvoting Common Stock | 18,000 | $12 | D | |
Stock Option (Right to Buy) | (3) | 06/30/2030 | Nonvoting Common Stock | 22,500 | $14 | D | |
Stock Option (Right to Buy) | (3) | 05/31/2031 | Nonvoting Common Stock | 13,889 | $16.14 | D | |
Stock Option (Right to Buy) | (4) | 06/30/2032 | Common Stock | 4,464 | $25.98 | D | |
Stock Option (Right to Buy) | (4) | 03/26/2033 | Common Stock | 2,786 | $19.84 | D | |
Stock Option (Right to Buy) | (4) | 10/31/2033 | Common Stock | 90 | $20.6 | D |
Explanation of Responses: |
1. The shares of Series B Preferred Stock are convertible on a one-for-one basis into shares of common stock commencing on the Company's initial public offering of its common stock ("IPO") effective date, which is August 13, 2025 and are held jointly with his spouse with right of survival. The Series B Preferred Stock has no expiration date. |
2. The shares of nonvoting common stock are convertible on a one-for-one basis into shares of common stock commencing at any time. Of his 14,083 shares of nonvoting common stock, (i) 10,000 are held in his individual name and (ii) 4,083 are held jointly with his spouse with right of survival. The nonvoting common stock has no expiration date. |
3. The options are fully vested. The options were granted initially as the right to buy nonvoting common stock. On the closing date of the IPO, these will convert to the right to buy common stock instead of nonvoting common stock. |
4. The options are fully vested. |
Remarks: |
See Exhibit 24.1 - Power of Attorney |
/s/Alessandra Maria Corona Henriques, Attorney-in-Fact | 08/13/2025 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |